A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury. ELASCI M16-077
Genetic correlation between metabolic profile of gliomas and prognosis”. Hospital Universitario La Paz- Autónoma University of Madrid-Institute of Biomedical Sciences. Madrid, Spain.
IDH mutational and immunoregulatory expression factors study in circulating tumor DNA and correlation with primary brain tumor in glioma patients. Promotor: Hospital Clínico San Carlos, Madrid, Spain.
GNOS (Global Neurotrauma Outcomes Study). Promotor: World Federation of Neurosurgical Societies (WFNS)
RESCUE- ASDH (rescueasdh.org). Promotor: Cambridge Neurosurgical Department- Cambridge University
Clinical trial Fase II BIOGEN 252BN201. Promotor: Astral
Miembro del Craniospain Research Group. Universidad La Salle-UAM, Madrid.
Clinical trial “Global registry to evaluate long-term efficacy of neurostimulation therapy for chronic pain”. RELIEF. Promotor: Boston Scientific International S.A.
Clinical trial “Precision Spectra neurostimulation system for chronic refractory back and extremities pain”. OPTIONS. Promotor: Boston Scientific International S.A.